CLX
BEARISH
$98.68
Live
The Clorox Company · NYSE
Target $115.47
(+17.0%)
$96.58
52W Range
$143.96
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 25, 2026
Market cap
$11.93B
P/E
16.15
ROE
987.2%
Profit margin
11.2%
Debt/Equity
91.91
Dividend yield
5.03%
AI Analysis
AI-powered fundamental assessment
Confidence
85%
The Clorox Company presents as a classic value trap, characterized by a stable Piotroski F-Score of 5/9 but severely undermined by a massive valuation gap, with a current price of $98.68 far exceeding its growth-based intrinsic value of $42.77. Financial health is concerning due to critical liquidity shortages, evidenced by a Quick Ratio of 0.38 and a Current Ratio of 0.74. Negative year-over-year revenue (-0.80%) and earnings (-16.20%) growth, combined with a 0/100 technical trend, indicate a strong bearish momentum. While the 5.03% dividend is attractive, the 80.52% payout ratio is increasingly risky given the declining earnings trajectory.
Key Strengths
Strong historical track record of beating earnings estimates
Healthy gross margins (44.16%) reflecting brand pricing power
Attractive dividend yield of 5.03% for income seekers
Positive operating margins (14.05%) despite growth headwinds
Analyst target price ($115.47) suggests potential recovery upside
Key Risks
Severe liquidity risk with a Quick Ratio of 0.38
Negative organic growth in both revenue and earnings
Extreme overvaluation relative to intrinsic value ($42.77)
High dividend payout ratio (80.52%) threatening sustainability
Persistent long-term price decline (-37.7% over 5 years)
AI Fair Value Estimate
Based on comprehensive analysis
$52.5
-46.8% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
36
Weak
30
25
20
45
60
AI Verdict
Value Trap
Key drivers: Negative growth metrics, Poor liquidity ratios, Severe technical downtrend, Intrinsic value disconnect
Confidence
90%
Value
30/100
Ref P/E, PEG, Intrinsic Value
Positives
- P/E ratio (16.15) is lower than sector average
Watchpoints
- PEG ratio of 2.01 indicates overvaluation relative to growth
- Price is >130% above intrinsic value estimate
Future
25/100
Ref Growth rates
Positives
- Recent Q/Q EPS growth spike (+63.5%)
Watchpoints
- Negative YoY Revenue Growth (-0.80%)
- Negative YoY Earnings Growth (-16.20%)
Past
20/100
Ref Historical trends
Positives
- Consistent history of earnings surprises
Watchpoints
- 5-year price change of -37.7%
- 1-year price change of -25.0%
Health
45/100
Ref Piotroski F-Score, Liquidity Ratios
Positives
- Piotroski F-Score of 5/9 indicates stability
Watchpoints
- Current Ratio (0.74) and Quick Ratio (0.38) are dangerously low
- Negative Price/Book ratio suggests equity depletion
Dividend
60/100
Ref Yield, Payout
Positives
- High yield of 5.03%
Watchpoints
- High payout ratio (80.52%) limits growth reinvestment
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$98.68
Analyst Target
$115.47
Upside/Downside
+17.0%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for CLX and closest competitors.
Updated 2026-04-24
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
CLX
The Clorox Company
Primary
|
-37.7% | -33.2% | -25.0% | -12.8% | -4.6% | -4.5% |
|
SFD
Smithfield Foods, Inc.
Peer
|
+55.3% | +55.3% | +48.7% | +33.6% | +24.5% | -0.8% |
|
BF-B
Brown-Forman Corporation
Peer
|
-57.8% | -56.3% | -14.3% | -9.6% | +2.5% | +4.4% |
|
BJ
BJ's Wholesale Club Holdings, Inc.
Peer
|
+124.1% | +40.4% | +0.4% | -6.5% | +3.1% | +4.3% |
|
BF-A
Brown-Forman Corporation
Peer
|
-53.5% | -55.7% | -13.0% | -8.0% | +4.2% | +4.7% |
CLX
The Clorox Company
Primary
5Y
-37.7%
3Y
-33.2%
1Y
-25.0%
6M
-12.8%
1M
-4.6%
1W
-4.5%
SFD
Smithfield Foods, Inc.
Peer
5Y
+55.3%
3Y
+55.3%
1Y
+48.7%
6M
+33.6%
1M
+24.5%
1W
-0.8%
BF-
Brown-Forman Corporation
Peer
5Y
-57.8%
3Y
-56.3%
1Y
-14.3%
6M
-9.6%
1M
+2.5%
1W
+4.4%
BJ
BJ's Wholesale Club Holdings, Inc.
Peer
5Y
+124.1%
3Y
+40.4%
1Y
+0.4%
6M
-6.5%
1M
+3.1%
1W
+4.3%
BF-
Brown-Forman Corporation
Peer
5Y
-53.5%
3Y
-55.7%
1Y
-13.0%
6M
-8.0%
1M
+4.2%
1W
+4.7%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
16.15
Forward P/E
14.73
PEG Ratio
2.01
P/B Ratio
-95.44
P/S Ratio
1.77
EV/Revenue
2.23
EV/EBITDA
12.28
Market Cap
$11.93B
Profitability
Profit margins and return metrics
Profit Margin
11.17%
Operating Margin
14.05%
Gross Margin
44.16%
ROE
987.18%
ROA
11.3%
Growth
Revenue and earnings growth rates
Revenue Growth
-0.8%
Earnings Growth
-16.2%
Q/Q Revenue Growth
-0.77%
Q/Q Earnings Growth
-18.7%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
91.91
High debt
Current Ratio
0.74
Weak
Quick Ratio
0.38
Poor
Cash/Share
$1.88
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$1.7B
Gross Margin
43.2%
Op. Margin
14.1%
Net Margin
9.4%
Total Assets
$5.6B
Liabilities
$5.6B
Equity
$-0.1B
Debt/Equity
-44.62x
Operating CF
$0.3B
CapEx
$-0.0B
Free Cash Flow
$0.3B
FCF Yield
86%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-04-30
$N/A
2026-02-03
$1.39
-3.0% surprise
2025-11-03
$0.85
+9.2% surprise
2025-07-31
$2.87
+29.8% surprise
Consumer Defensive Sector Comparison
Comparing CLX against 146 companies in the Consumer Defensive sector
(8 bullish, 52 neutral, 86 bearish)
P/E Ratio
16.15
This Stock
vs
34.01
Sector Avg
-52.5%
(Discount)
Return on Equity (ROE)
987.18%
This Stock
vs
-14.23%
Sector Avg
-7035.1%
(Below Avg)
Profit Margin
11.17%
This Stock
vs
-8.48%
Sector Avg
-231.7%
(Weaker)
Debt to Equity
91.91
This Stock
vs
2.03
Sector Avg
+4419.1%
(Higher)
Revenue Growth
-0.8%
This Stock
vs
128.59%
Sector Avg
-100.6%
(Slower)
Current Ratio
0.74
This Stock
vs
2.44
Sector Avg
-69.8%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
CLX
The Clorox Company
|
BEARISH | $11.93B | 16.15 | 987.2% | 11.2% | $98.68 | |
|
SFD
Smithfield Foods, Inc.
|
BULLISH | $11.41B | 11.55 | 15.2% | 6.4% | $29.0 | Compare |
|
BF-B
Brown-Forman Corporation
|
NEUTRAL | $12.77B | 16.31 | 20.7% | 20.8% | $27.57 | Compare |
|
BJ
BJ's Wholesale Club Holdings, Inc.
|
NEUTRAL | $12.84B | 22.45 | 29.2% | 2.7% | $97.45 | Compare |
|
BF-A
Brown-Forman Corporation
|
BEARISH | $12.91B | 16.49 | 20.7% | 20.8% | $27.86 | Compare |
CLX
The Clorox Company
BEARISH
Mkt Cap
$11.9B
P/E
16.2
ROE
987.2%
Price
$98.68
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-21 | BREBER PIERRE R. | Director | Purchase | 4,000 | $416,516 |
BREBER PIERRE R.
Director
2025-11-21
4,000 shares
·
$416,516
Insider transactions can signal confidence or concerns about company prospects
SEC Filings
Recent regulatory filings from the SEC EDGAR database
8-K
10-Q
8-K
8-K
8-K
10-Q
8-K
8-K
DEF 14A
Data sourced from SEC EDGAR. AI summaries generated automatically.
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
HOLD
17 analysts
Morgan Stanley
2026-04-23
Equal-Weight
Equal-Weight
Jefferies
2026-04-21
Buy
Buy
JP Morgan
2026-04-17
Neutral
Underweight
Citigroup
2026-04-15
Neutral
Neutral
Barclays
2026-04-15
Underweight
Underweight
Barclays
2026-04-14
Underweight
Underweight
Wells Fargo
2026-04-08
Equal-Weight
Equal-Weight
UBS
2026-04-07
Neutral
Neutral
Deutsche Bank
2026-03-30
Hold
Hold
Morgan Stanley
2026-02-05
Equal-Weight
Equal-Weight
Past News Coverage
Recent headlines mentioning CLX from our newsroom.
Newest → oldest
No matching news yet.